No Data
Abbott Laboratories: Strategic Advancements and Market Positioning With Volt PFA Platform Drive Buy Rating
Abbott Highlights New AVEIR Data, Initiates Trial for the Company's Conduction System Pacing Technology
Express News | Abbott Laboratories - 83.5% Paf and 58.1% Persaf Patients Arrhythmia-Free After 12 Months
Express News | New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ Pfa System for Patients With Afib
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt PFA System for Patients With AFib
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
